IL6 and COVID-19: Immunomodulatory therapies (IMT) (e.g., corticosteroids, IL‐6 inhibitors, GM‐CSF inhibitors, methotrexate, calcineurin inhibitors, and antitumor necrosis factor agents) have been used to treat the hyperinflammatory response seen in severe or critical COVID-19 [101].